MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

Altimmune, Inc. (ALT)

Altimmune, Inc. (ALT)

|||

Balance Sheets Overview

Current Ratio
2678.31%
Quick Ratio
2678.31%
Cash Ratio
504.02%
Debt to Asset Ratio
10.05%
Unit: Thousand (K) dollars
Assets Breakdown
    • Short-term investments
    • Cash and cash equivalents
    • Prepaid expenses and other curre...
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accumulated other comprehensive ...
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-09-30
2025-06-30
Cash and cash equivalents
63,008
97,601
61,236
183,105
Restricted cash
42
42
42
42
Total cash, cash equivalents and restricted cash
63,050
97,643
61,278
183,147
Short-term investments
263,273
233,939
149,540
-
Accounts and other receivables
3,341
1,665
845
321
Income tax and r&d incentive receivables
-
-
547
557
Prepaid expenses and other current assets
5,151
1,429
4,405
4,397
Total current assets
334,815
334,676
216,615
188,422
Long-term investments
192,247
-
-
-
Property and equipment, net
60
208
337
364
Other assets
90
746
1,495
1,564
Total assets
527,212
335,630
218,447
190,350
Accounts payable
1,272
1,530
4,804
851
Accrued expenses and other current liabilities
11,229
9,793
7,802
8,369
Total current liabilities
12,501
11,323
12,606
9,220
Term loan, noncurrent
34,742
34,505
14,445
14,332
Other noncurrent liabilities
5,761
5,815
5,795
5,431
Total liabilities
53,004
51,643
32,846
28,983
Common stock, 0.0001 par value 400,000,000 and 200,000,000 shares authorized 194,474,154 and 110,882,735 shares issued and outstanding as of june 30, 2026 and december 31, 2025, respectively
19
13
10
9
Additional paid-in capital
1,175,098
961,244
812,732
769,508
Accumulated deficit
-694,871
-672,046
-622,125
-603,111
Accumulated other comprehensive loss, net
-6,038
-5,224
-5,016
-5,039
Total stockholders' equity
474,208
283,987
185,601
161,367
Total liabilities and stockholders' equity
527,212
335,630
218,447
190,350
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$63,008K (-65.59%↓ Y/Y)Restricted cash$42K (0.00%↑ Y/Y)Short-term investments$263,273K Total cash, cashequivalents and restricted...$63,050K (-65.57%↓ Y/Y)Prepaid expenses andother current assets$5,151K (17.15%↑ Y/Y)Accounts and otherreceivables$3,341K (940.81%↑ Y/Y)Total current assets$334,815K (77.69%↑ Y/Y)Long-term investments$192,247K Other assets$90K (-94.25%↓ Y/Y)Property and equipment,net$60K (-83.52%↓ Y/Y)Total assets$527,212K (176.97%↑ Y/Y)Total liabilities andstockholders' equity$527,212K (176.97%↑ Y/Y)Total stockholders'equity$474,208K (193.87%↑ Y/Y)Total liabilities$53,004K (82.88%↑ Y/Y)Accumulated deficit-$694,871K (-15.21%↓ Y/Y)Accumulated othercomprehensive loss, net-$6,038K (-19.83%↓ Y/Y)Additional paid-in capital$1,175,098K (52.71%↑ Y/Y)Term loan,noncurrent$34,742K (142.41%↑ Y/Y)Total currentliabilities$12,501K (35.59%↑ Y/Y)Other noncurrentliabilities$5,761K (6.08%↑ Y/Y)Common stock, 0.0001par value...$19K (111.11%↑ Y/Y)Accrued expenses andother current...$11,229K (34.17%↑ Y/Y)Accounts payable$1,272K (49.47%↑ Y/Y)